230 related articles for article (PubMed ID: 16688597)
1. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P
Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
[TBL] [Abstract][Full Text] [Related]
2. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.
Di Rosa M; Dell'Ombra N; Zambito AM; Malaguarnera M; Nicoletti F; Malaguarnera L
Eur J Neurosci; 2006 May; 23(10):2648-56. PubMed ID: 16817867
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
[TBL] [Abstract][Full Text] [Related]
4. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.
Zetterberg H; Andreasen N; Blennow K
Neurosci Lett; 2004 Sep; 367(2):194-6. PubMed ID: 15331151
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.
Mocali A; Cedrola S; Della Malva N; Bontempelli M; Mitidieri VA; Bavazzano A; Comolli R; Paoletti F; La Porta CA
Exp Gerontol; 2004 Oct; 39(10):1555-61. PubMed ID: 15501026
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Paraskevas GP; Kapaki E; Nikolaou C; Zoga M; Rombos A; Tsoutsou A; Vassilopoulos D D
J Neurol Sci; 2006 Nov; 249(2):110-4. PubMed ID: 16843497
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus.
Heep A; Stoffel-Wagner B; Bartmann P; Benseler S; Schaller C; Groneck P; Obladen M; Felderhoff-Mueser U
Pediatr Res; 2004 Nov; 56(5):768-74. PubMed ID: 15319463
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
[TBL] [Abstract][Full Text] [Related]
9. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
[TBL] [Abstract][Full Text] [Related]
10. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
[TBL] [Abstract][Full Text] [Related]
11. Circulating interleukin-10 and interleukin-12 in Parkinson's disease.
Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
Acta Neurol Scand; 2009 May; 119(5):332-7. PubMed ID: 18976327
[TBL] [Abstract][Full Text] [Related]
12. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.
Motta M; Imbesi R; Di Rosa M; Stivala F; Malaguarnera L
Immunol Lett; 2007 Nov; 114(1):46-51. PubMed ID: 17949824
[TBL] [Abstract][Full Text] [Related]
13. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
[TBL] [Abstract][Full Text] [Related]
14. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
Katagiri K; Arakawa S; Hatano Y
Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in Alzheimer's disease and vascular dementia.
Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
[TBL] [Abstract][Full Text] [Related]
19. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
Wada-Isoe K; Wakutani Y; Urakami K; Nakashima K
Acta Neurol Scand; 2004 Aug; 110(2):124-7. PubMed ID: 15242421
[TBL] [Abstract][Full Text] [Related]
20. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D
J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]